Dopaminergic hypofunction — the insufficiency or underactivation of dopaminergic neurotransmission — occupies a pivotal, if contested, position within the depth-psychology and neuropsychoanalytic corpus. The term surfaces most systematically in Blum and colleagues’ elaboration of Reward Deficiency Syndrome, where hypofunctional dopamine signaling, particularly at the D2 receptor, is posited as the neurogenetic substrate underlying a spectrum of compulsive, addictive, and attentional disorders including ADHD. Here, dopaminergic hypofunction is not merely a pharmacological datum but a heritable constitutional vulnerability that shapes motivational architecture from childhood onward. Koob’s neurocircuitry framework extends this logic to addiction, identifying decreased dopaminergic reward-system function during withdrawal as a driver of negative affect and relapse. Wynchank introduces a sex-specific dimension, demonstrating that oestrogen-modulated dopamine availability renders women with ADHD particularly susceptible to cyclic hypofunctional states during the luteal phase. Berridge, by contrast, complicates any simple hypofunction narrative: his incentive-sensitization work shows that dopamine governs ‘wanting’ rather than ‘liking,’ and that dopamine suppression in Parkinson’s patients does not straightforwardly produce addictive compulsion. Schore’s developmental perspective situates mesocortical dopaminergic activity within early attachment and orbitofrontal maturation, implying that environmental deprivation can induce functionally analogous hypofunctional states. The corpus thus presents dopaminergic hypofunction as simultaneously genetic, developmental, hormonal, and circuit-level in its origins and consequences.
increases in negative emotional states and dysphoric and stress-like responses in the withdrawal/negative affect stage involve decreases in the function of the dopamine component of the reward system
Koob identifies dopaminergic hypofunction during withdrawal as the neurobiological engine of negative affect and relapse vulnerability in addiction.
, Neurobiology of addiction: a neurocircuitry analysis, 2016thesis
the Le Moal and Simon (1991) and Shaywitz et al (1976) dopamine deficiency animal models of ADHD, (k) the norepinephrine models of ADHD, (l) the failure to explain ADHD on the basis of any single neurotransmitter
Blum marshals animal models of dopamine deficiency as foundational evidence for the dopaminergic hypofunction hypothesis of ADHD within the broader Reward Deficiency Syndrome framework.
, Attention-deficit-hyperactivity disorder and reward deficiency syndrome, 2008thesis
ovarian hormone-related dopaminergic dysregulation is particularly severe during the luteal phase in women with ADHD, resulting in worsening symptoms and reduced medication efficacy
Wynchank argues that oestrogen withdrawal during the luteal phase intensifies dopaminergic hypofunction in women with ADHD, producing cyclically amplified attentional and emotional deficits.
, Menstrual Cycle-Related Hormonal Fluctuations in ADHD: Effect on Cognitive Functioning—A Narrative Review, 2025thesis
women with ADHD have an even higher reuptake and lower availability of dopamine than their male counterparts. Rapidly declining oestrogen levels during the pre-menstrual phase, combined with altered dopamine functioning, may then contribute to impairments in attention, executive function and inhibitory processes
Wynchank proposes a sex-differentiated baseline of dopaminergic hypofunction in ADHD that is further exacerbated by hormonal fluctuation.
, Menstrual Cycle-Related Hormonal Fluctuations in ADHD: Effect on Cognitive Functioning—A Narrative Review, 2025supporting
the relationship between dopamine D2 receptor density and regional blood flow, (g) the correlation between cerebral spinal fluid homovanilic acid levels and DRD2 genotypes
Blum correlates reduced D2 receptor density and diminished dopamine metabolite levels with the neuroimaging and genetic signatures of reward-deficient, hypofunctional dopaminergic states in ADHD.
, Attention-deficit-hyperactivity disorder and reward deficiency syndrome, 2008supporting
Parkinson’s patients are in dopamine suppression states prior to medication or if taken off medication, but no longer have compulsive motivations
Berridge uses Parkinson’s dopamine suppression as a counterexample, arguing that hypofunction alone does not generate addictive wanting, thereby challenging simplistic hypofunction-equals-compulsion models.
, Liking, Wanting, and the Incentive-Sensitization Theory of Addiction, 2016supporting
antipsychotic drugs help only with the positive symptoms of schizophrenia. They mitigate and even abolish delusions, hallucinations, and some types of disordered thinking without significantly affecting the negative or cognitive symptoms
Kandel’s account of D2-receptor pharmacology in schizophrenia implies that dopaminergic hypofunction underlies the negative and cognitive symptom clusters untouched by receptor blockade.
, In search of memory the emergence of a new science of mind, 2006supporting
a nutraceutical (nutrigenomic) approach targeted at enhancing slow dopamine release in the nucleus accumbens
Blum proposes nutrigenomic supplementation to correct dopaminergic hypofunction at the nucleus accumbens as a therapeutic strategy for ADHD and Reward Deficiency Syndrome.
, Attention-deficit-hyperactivity disorder and reward deficiency syndrome, 2008supporting
experience-dependent growth of ventral tegmental mesocortical dopamine terminals into orbitofrontal regions
Schore situates dopaminergic system development within early relational experience, implying that attachment failures can produce functionally hypofunctional mesocortical dopamine circuitry.
, Affect Regulation and the Origin of the Self: The Neurobiology of Emotional Development, 1994supporting
increased activity of the mesocortical dopamine system that is known to support locomotion and investigatory exploration behavior
Schore identifies mesocortical dopaminergic activity as the neurobiological substrate of exploratory motivation, against the background of which hypofunction would manifest as diminished affect and initiative.
, Affect Regulation and the Origin of the Self: The Neurobiology of Emotional Development, 1994supporting
the A1 allele of the dopamine D2 receptor ge[ne]
Blum links the DRD2 A1 allele — associated with reduced receptor density — to heritable dopaminergic hypofunction across ADHD, alcoholism, and antisocial personality.
, Attention-deficit-hyperactivity disorder and reward deficiency syndrome, 2008supporting
the mesocortical dopamine system is a good candidate for emotional conditioning, since it is centrally involved in emotionality, in exploratory behavior, and in stimulant and opioid conditioning effects
Schore identifies the mesocortical dopamine system’s role in emotional conditioning, providing developmental context for understanding what is lost when this system is hypofunctional.
, Affect Regulation and the Origin of the Self: The Neurobiology of Emotional Development, 1994aside
bilateral lesions in the ventromesial frontal white matter cause complete cessation of dreaming in association with adynamia and other disorders of volitional interest
Solms’ neuroanatomical finding that motivational-system lesions abolish dreaming bears oblique relevance to dopaminergic hypofunction insofar as mesocortical dopamine drives the volitional states he identifies as essential to dream generation.
, Dreaming and REM Sleep Are Controlled by Different Brain Mechanisms, 2000aside